Optimizing Gastroenterology Rhyme with Klivira's Prior Authorization Automation

For gastroenterology practices, achieving a smooth 'Rhyme' in prior authorization workflows is critical for financial health and patient access. Klivira delivers intelligent automation tailored to the unique demands of GI.

Gastroenterology presents a complex landscape for prior authorization, characterized by high-volume biologics, specialty drugs, and diagnostic procedures. Revenue cycle directors and prior authorization coordinators face significant administrative burdens managing these requests, often leading to delays in patient care and increased denial rates. Klivira's platform is engineered to integrate seamlessly, transforming the prior authorization process for GI specialists.

The Unique Prior Authorization Landscape in Gastroenterology

GI prior authorization is heavily concentrated in high-cost biologics for inflammatory bowel disease (IBD), direct-acting antivirals for Hepatitis C, advanced imaging, and specific endoscopic procedures. The chronic nature of many GI conditions, such as Crohn's disease and ulcerative colitis, means ongoing re-authorizations and a continuous administrative workload for practices.

Key PA Triggers in GI Workflows

**IBD Biologics:** Including TNF inhibitors (adalimumab/Humira, infliximab/Remicade), integrin inhibitors (vedolizumab/Entyvio), IL-12/23 inhibitors (ustekinumab/Stelara, risankizumab/Skyrizi), JAK inhibitors (tofacitinib/Xeljanz, upadacitinib/Rinvoq), and S1P modulators (ozanimod/Zeposia, etrasimod/Velsipity).
**Hepatitis C DAAs:** Such as sofosbuvir-velpatasvir (Epclusa) and glecaprevir-pibrentasvir (Mavyret), with distinct pathways for treatment-naive vs. experienced patients.
**Advanced Imaging:** MRCP, MR enterography, and CT enterography for IBD assessment and other abdominal imaging.
**Endoscopic Procedures:** Specific PA requirements for capsule endoscopy (CPT 91110), small-bowel enteroscopy, ERCP, and EUS.
**Specialty Drugs for Functional GI Disorders:** Including eluxadoline (Viberzi), prucalopride (Motegrande), linaclotide (Linzess), and plecanatide (Trulance).

Navigating Payer Policies and Clinical Guidelines for GI

Successful prior authorization in gastroenterology hinges on precise adherence to clinical guidelines from bodies like ACG, AGA, and AASLD. Payers frequently require detailed documentation on diagnosis confirmation, disease severity (e.g., Mayo score, CDAI), prior conventional and biologic therapy trials, and comprehensive screening results (e.g., TB, hepatitis pre-biologic). Klivira's platform incorporates these evidence-based criteria into its logic.

Common Denial Drivers in Gastroenterology Prior Auth

**Step Therapy Non-Compliance:** Failure to document trial of conventional therapies or required biologic sequencing (e.g., TNF before non-TNF agents).
**Biosimilar Substitution:** Denial of brand-name TNF inhibitors when a biosimilar is mandated by payer policy.
**Inadequate Disease Severity Documentation:** Missing or incomplete Mayo score, CDAI, or other required severity measures.
**Screening Gaps:** Lack of documented TB or hepatitis screening prior to biologic initiation.
**Treatment Status Misclassification:** Incorrectly classifying patients as treatment-naive vs. treatment-experienced for IBD biologics or Hep C DAAs.

Klivira's Intelligent Approach to Gastroenterology Prior Authorization

Klivira streamlines the gastroenterology rhyme by automating the submission and tracking of prior authorizations. Our platform integrates with existing EMR systems, pulling relevant clinical data to populate requests accurately. This includes automating documentation for ACG/AGA-guideline-aware step therapy logic for IBD biologics, treatment-status classification from EMR medication history, and specific workflows for Hep C DAA documentation.

Seamless Integration for GI Practice Efficiency

Klivira connects directly with payer portals and leverages X12 278 transactions where available, ensuring prior authorization requests are submitted through the most efficient channels. The system also manages periodic re-authorization workflows for chronic GI treatments and intelligently routes requests based on medical-vs-pharmacy benefit distinctions for biologic agents, adapting to changes in administration modes over time.

Frequently asked questions

How does Klivira handle step therapy requirements for IBD biologics?

Klivira's platform incorporates ACG/AGA-guideline-aware step therapy logic. It leverages EMR data to identify prior therapy trials and ensures documentation aligns with payer-specific requirements, helping to avoid denials related to step therapy non-compliance.

Can Klivira manage the medical vs. pharmacy benefit split for GI specialty drugs?

Yes, Klivira is designed to manage the complexities of medical vs. pharmacy benefit for biologic IBD drugs. It intelligently routes authorization requests based on the administration mode (provider-administered infusion vs. self-administered injection), adapting as patient treatment plans evolve.

Does Klivira automate re-authorizations for chronic GI conditions like Crohn's or UC?

Absolutely. For chronic conditions requiring ongoing treatment, such as IBD, Klivira automates the periodic re-authorization workflow. This ensures timely submission of updated clinical documentation and helps prevent lapses in patient care due to expired authorizations.

How does Klivira integrate with our EMR to gather necessary GI documentation?

Klivira integrates securely with your EMR system, pulling critical clinical data such as medication history for treatment status classification, diagnosis codes, lab results (e.g., genotype, fibrosis stage for Hep C), and disease severity scores. This reduces manual data entry and improves the accuracy of PA submissions.

What specific GI procedures does Klivira help authorize?

Klivira supports prior authorization for a range of GI procedures including advanced imaging like MRCP and CT enterography, and endoscopic procedures such as capsule endoscopy (CPT 91110), small-bowel enteroscopy, ERCP, and EUS. Our system helps ensure the necessary clinical documentation is present for each request.